May 02, 2025

Digital Monitoring App Improves Asthma Quality of Life in Trial

A digital asthma symptom monitoring app modestly improved patient-reported quality of life, with greater benefits seen in younger adults and those with low self-management skills.

Conexiant

May 02, 2025

Personalizing Eating Disorder Care Advances, Study

A global research team reviewed current treatments for eating disorders and found that while personalization is seen as essential by patients and clinicians, most approaches still lack strong supporting evidence.

Conexiant

May 01, 2025

Phthalates Linked to Cardiovascular Mortality Globally

Researchers linked di-2-ethylhexylphthalate plastic exposure to over 350,000 cardiovascular deaths and 10 million years of life lost, supporting calls for international regulatory measures.

Conexiant

May 01, 2025

EdgeOne Blaze Utopia™ From EdgeEndo: Efficiency, Safety, and Flexibility

Patel notes how the unique heat-treated design of the EdgeOne Blaze improves its performance and longevity compared to other files he’s used.

Compendium

May 01, 2025

Glaucoma: A Toxic Relationship

Several studies do establish diabetes as a risk factor for glaucoma, and that diabetes with coexisting glaucoma increases the risk of developing diabetic retinopathy.

Optometric Management

May 01, 2025

Clinical Trial Update May 2025

Access Retinal Physician's listing of all active clinical trials in AMD, DME, RVO, and uveitis.

Retinal Physician

May 01, 2025

Stem Cell Therapies for Retinal Degenerations

Stem cell therapy harnesses the high regenerative potency of undifferentiated stem cells to replace diseased or dead cells. In recent years, stem cell therapy for retinal diseases has transitioned from preclinical investigation to early phase clinical trials with promising results. Both RPE replacement and photoreceptor transplantation strategies have shown the potential to preserve or restore visual function in conditions like AMD and RP, offering hope for conditions once considered irreversible.

Retinal Physician

May 01, 2025

Diabetic Retinopathy and Glucagon-Like Peptide-1 Agonists

Glucagon-like peptide-1 agonists (GLP-1), popular choices for the second-line treatment of type 2 diabetes and, most recently, obesity, are connected with diabetic retinopathy.

Optometric Management

May 01, 2025

Coding: Billing for Diabetes

If this were your patient who has diabetes, how would you determine whether to bill this patient’s vision plan coverage or medical insurance?

Optometric Management